Form 4: Hims & Hers CLO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, sold 4,812 shares of Class A Common Stock for $24.69 per share under a pre-arranged trading plan.

Summary

  • Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), reported a sale of company stock.
  • The transaction involved the disposition of 4,812 shares of Class A Common Stock.
  • The shares were sold at a price of $24.69 per share.
  • The total value of the shares sold was approximately $118,869.48.
  • Following this transaction, Soleil Boughton beneficially owns 308,831 shares of Class A Common Stock.
  • The sale was executed on March 17, 2026, pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executives managing personal portfolios through pre-arranged trading plans, and not directly reflecting on the company's operational performance or immediate prospects.

Industry Context

StockSavvy.ai notes that insider sales executed under a Rule 10b5-1 trading plan are pre-scheduled transactions designed to allow insiders to sell shares without being accused of trading on material non-public information. Such sales are generally considered routine and often reflect personal financial planning rather than a change in management's outlook on the company's immediate prospects.

Stakeholder Impact

  • Shareholders may note the insider sale, but given it was executed under a pre-arranged 10b5-1 plan, the immediate impact on investor sentiment is typically minimal as it is not indicative of new information.

Key Dates

DateDescription
11/18/2025Rule 10b5-1 trading plan adopted by the Reporting Person.
03/17/2026Date of transaction for the sale of Class A Common Stock.
03/18/2026Date the Form 4 was signed and filed.

Recommendation

hold

The sale by the Chief Legal Officer was executed under a pre-arranged 10b5-1 trading plan, indicating it was scheduled in advance and not necessarily a reaction to new, material non-public information. Such routine transactions generally do not provide a strong signal for a change in investment strategy.

Keywords

Hims & Hers Health, HIMS, Insider Trading, Form 4, Stock Sale, Soleil Boughton, Chief Legal Officer, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.